# Strix launches £10 million tender offer at 43p per share

- Link: https://www.directorstalkinterviews.com/strix-launches-10-million-tender-offer-at-43p-per-share/4121248393
- Published: 2026-04-09T07:16:49+01:00
- Author: Amilia Stone

**[Strix Group plc](https://www.directorstalkinterviews.com/company/strix-group-plc/ketl.l)**(
LON:KETL), the global leader in the design, manufacture and supply of kettle safety
controls and other components and devices involving water heating and temperature
control, steam management and water filtration, has announced the launch of the 
proposed return of capital up to £10 million to Shareholders by way of a tender 
offer.

**Tender Offer highlights**

·     The Tender Offer will return up to £10 million to Eligible Shareholders at
a Tender Price of 43 pence per Ordinary Share, representing a premium of 10.5 per
cent. to the closing price of 38.9 pence per Ordinary Share on 8 April 2026 (being
the Latest Practicable Date).

·     The Tender Offer will represent up to approximately 10.1 per cent. of the 
Company’s issued Ordinary Share capital as at the Latest Practicable Date .

·     The Tender Offer is conditional on, amongst other things, the Company being
in receipt of valid tenders in respect of at least 5,813,953 Ordinary Shares and
the approval of the Resolution (as defined below) by Shareholders.

The Tender Offer will open on 10 April 2026 (unless such date is altered), and tenders
submitted before that date will not be accepted. The Tender Offer will close at 
1.00 p.m. on 30 April 2026, and tenders received after that time will not be accepted(
unless the Closing Date is extended).

**Background to and reasons for the Tender Offer**

In September 2025, the Board announced its intention to implement an accelerated
debt reduction programme, in response to a marked slowdown in the Controls division
and a more challenging macroeconomic backdrop, including inflationary pressures 
on commodity prices. This programme was designed to enhance working capital efficiency,
maintain access to cost-effective funding and position the Group for a successful
future refinance.

Subsequently, in Q425, the Board received an unsolicited offer for the Group’s Billi
division, valuing the business at an aggregate consideration of £110.0 million. 
Following careful evaluation, the Board concluded that the offer represented an 
attractive opportunity to realise value, delivering an absolute return of c.3x on
the Group’s original investment. The disposal was therefore deemed to be the optimal
route to accelerate deleveraging, materially strengthen the balance sheet and remove
reliance on future debt funding.

Completion of the disposal of Billi was announced on 30 January 2026, generating
net proceeds (after estimated closing adjustments) of c.£105 million. The transaction
represented a significant inflection point for the Group, resulting in a strong 
net cash position of c.£35 million at completion and providing a robust financial
platform for the Group’s next phase of development.

Following completion, the Group prioritised balance sheet optimisation, utilising
the net proceeds to  repay its existing multi-bank debt facilities, whilst retaining
access to a £25 million undrawn revolving credit facility which provides additional
liquidity and financial flexibility.  As a result, annual net interest costs are
expected to reduce significantly to below £1 million (CY25: c.£7.5 million), enhancing
cash flow generation and supporting future capital allocation initiatives.

On 4 February 2026, the Group also commenced a £10 million share buyback programme.
To date, 8,357,417 Ordinary Shares have been purchased under that programme for 
an aggregate consideration of c.£3.4 million, at an average price of c.41.2 pence
per share. This programme reflects the Board’s ongoing commitment to enhancing shareholder
returns. The Company has paused the Buyback Programme until after completion of 
the Tender Offer.

In addition to the current share buyback programme, the Board has reviewed the various
options for returning capital to Shareholders, as well as noting the share price
development, and concluded that the Tender Offer represents the most appropriate
and efficient mechanism, enabling all eligible shareholders (excluding those in 
restricted jurisdictions) to participate on an equitable basis.

Strix Group will announce a full capital allocation framework (which will include
strategic investment growth opportunities)  later in the year as part of a wider
strategic update.

**General Meeting**

The Company will require authority from Shareholders to purchase Ordinary Shares
in connection with the Tender Offer and is convening  a General Meeting to be held
at the offices of the Company at Forrest House, Ronaldsway, Isle of Man, IM9 2RG,
at 9.00 a.m. on 30 April 2026 (the “General Meeting”) for the purposes of seeking
approval of a special resolution to grant authority to the Company to make purchases
of Ordinary Shares. Whether or not Shareholders intend to attend the General Meeting,
Shareholders are encouraged to appoint a proxy to vote on the Resolution as soon
as possible in the manner set out in the Circular (as defined further below).

A shareholder circular, containing the full terms and conditions of the Tender Offer,
instructions to Eligible Shareholders on how to tender their Ordinary Shares and
a notice convening the General Meeting, will be despatched to Shareholders today.

The Circular will also be available on the Company’s website at https://strix.com/
documents-reports.html.

A summary of the key terms of the Tender Offer is included later in this announcement
under the heading “Additional Information”.

This announcement should be read in conjunction with the full text of the Circular.
Certain capitalised terms used in this announcement have the meanings given to them
in the Circular.

**EXPECTED TIMETABLE FOR PRINCIPAL EVENTS^(1, 2)**

| Announcement of Tender Offer | 9 April 2026 | 
| Publication and posting of Circular and Tender Form | 9 April 2026 | 
| Tender Offer opens | 10 April 2026 | 
| Latest time and date for receipt of Forms of Proxy for the General Meeting | 9.00 a.m. on 28 April 2026 | 
| Voting Record Time | 6.00 p.m. on 28 April 2026 | 
| General Meeting | 30 April 2026 | 
| Announcement of results of the General Meeting | 30 April 2026 | 
| Latest time and date for receipt of Tender Forms and settlement of TTE Instructions (i.e. Closing Date of the Tender Offer)^(3) | 1.00 p.m. on 30 April 2026 | 
| Record Date for the Tender Offer | 6.00 p.m. on 30 April 2026 | 
| Announcement of the result of the Tender Offer | 5 May 2026 | 
| Expected purchase of Ordinary Shares under the Tender Offer and completion of the repurchase of Ordinary Shares from Zeus | 14 May 2026 | 
| CREST accounts credited with unsuccessfully tendered Ordinary Shares | 14 May 2026 | 
| CREST accounts credited with Tender Offer proceeds | 14 May 2026 | 
| Despatch of cheques for Tender Offer proceeds in respect of successfully tendered certificated Ordinary Shares and despatch of balancing share certificates in respect of unsold certificated Ordinary Shares | 14 May 2026 |

**Notes**

1.     All references to times throughout this Announcement are to London time.

2.    If any of the above times and/or dates change, the revised times and/or dates
will be notified by the Company by an announcement through a Regulatory Information
Service.

3.    This date may be extended in accordance with the terms and conditions of the
Tender Offer set out in Part V of the Circular.

4.    All events in the above timetable following the General Meeting that relate
to the Tender Offer are conditional, inter alia, upon the approval of the Resolution.
The Resolution requires the approval of not less than 75 per cent. of the votes 
cast by Shareholders in person or by proxy at the General Meeting. It should be 
noted that non-binding Letters of Intent to vote in favour of the Resolution have
been received from Shareholders holding, in aggregate, 20.8 per cent. of the issued
share capital of the Company. See paragraph 5 of Part IV of the Circular for further
details.

5.   Subject to and following the Tender Offer becoming unconditional, settlement
of the consideration to which any Eligible Shareholder is entitled pursuant to valid
tenders accepted by Zeus will be made within 14 days of the Closing Date.

**ADDITIONAL INFORMATION**

**Details of the Tender Offer**

The Tender Offer is being made, on behalf of the Company by Zeus (acting as principal
and not as agent, nominee or trustee), to all Eligible Shareholders. For legal and
regulatory reasons, the Company is unable to make the opportunity to participate
in the Tender Offer available to Shareholders who are resident in the Restricted
Jurisdictions. Full details of the Tender Offer, including the terms and conditions
on which it is being made, are set out in Part V of the Circular and in the Tender
Form (as applicable).

Zeus (acting as principal and not as agent, nominee or trustee) will acquire Ordinary
Shares from Eligible Shareholders up to a value of £10 million. At the Tender Price
of 43 pence per Ordinary Share, this equates to a maximum of 23,255,813 Ordinary
Shares, representing approximately 10.1 per cent. of the Company’s current issued
share capital at the Latest Practicable Date.

The Tender Price of 43 pence per Ordinary Share represents a premium of 10.5 per
cent. to the closing price of 38.9 pence per Ordinary Share on the Latest Practicable
Date.

All Eligible Shareholders who are on the Register at 6.00 p.m. on 28 April 2026 
are entitled, but not required, to tender some or all of their Ordinary Shares for
purchase by Zeus (acting as principal and not as agent, nominee or trustee) pursuant
to the terms and conditions set out in the Circular. Each Eligible Shareholder will
have a Basic Entitlement to tender Ordinary Shares, being approximately 10.1 per
cent. of the Ordinary Shares held by them at the Record Date (rounded down to the
nearest whole number). Because the Basic Entitlement is calculated by reference 
to each Eligible Shareholder’s holding at the Record Date, the exact number of Ordinary
Shares comprising each Eligible Shareholder’s Basic Entitlement will not be known
until after the Record Date.

Eligible Shareholders may tender Ordinary Shares up to and including their Basic
Entitlement, or may tender a greater number of Ordinary Shares if they wish. Following
the Record Date, the Company and the Receiving Agent will calculate each Eligible
Shareholder’s Basic Entitlement and determine whether the number of Ordinary Shares
tendered by that Eligible Shareholder falls within, equals, or exceeds their Basic
Entitlement. Tenders up to and including an Eligible Shareholder’s Basic Entitlement
will be satisfied in full (subject to valid tender). Any Ordinary Shares tendered
in excess of an Eligible Shareholder’s Basic Entitlement (an “Excess Entitlement”)
will only be satisfied to the extent that other Eligible Shareholders have tendered
less than their Basic Entitlement. To the extent that Excess Entitlement tenders
cannot be satisfied in full, such tenders will be scaled back on a pro rata basis
among those Eligible Shareholders who have tendered an Excess Entitlement, at the
discretion of Zeus and the Company.

Eligible Shareholders are not obliged to tender any Ordinary Shares if they do not
wish to do so. If no action is taken by Eligible Shareholders, there will be no 
change to the number of Ordinary Shares that they hold and they will receive no 
cash as a result of the Tender Offer.

The total number of Ordinary Shares tendered by any Eligible Shareholder must not
exceed the total number of Ordinary Shares registered in the name of that Eligible
Shareholder at the Record Date. Once made, any tender of Ordinary Shares will be
irrevocable.

The Tender Offer will open on 10 April 2026 (unless such date is altered), and tenders
submitted before that date will not be accepted. The Tender Offer will close at 
1.00 p.m. on 30 April 2026, and tenders received after that time will not be accepted(
unless the Closing Date is extended).

If the aggregate number of Ordinary Shares validly tendered by Eligible Shareholders
is equal to or less than 23,255,813 Ordinary Shares (being the maximum number of
Ordinary Shares to be purchased pursuant to the Tender Offer), then all Ordinary
Shares validly tendered will be accepted and purchased at the Tender Price. If the
aggregate number of Ordinary Shares validly tendered exceeds 23,255,813Ordinary 
Shares, tenders will be satisfied as follows: (i) all Ordinary Shares validly tendered
up to and including an Eligible Shareholder’s Basic Entitlement will be accepted
and purchased in full at the Tender Price; and (ii) Ordinary Shares validly tendered
by Eligible Shareholders in excess of their Basic Entitlement will be accepted and
purchased only to the extent that there are Ordinary Shares available for purchase
as a result of other Eligible Shareholders not having tendered their full Basic 
Entitlement, with such excess tenders being scaled back on a pro rata basis among
those Eligible Shareholders who have tendered in excess of their Basic Entitlement,
at the discretion of Zeus and the Company.

The maximum cost to the Company from the Tender Offer will be £10 million (before
expenses). This will be funded from the cash balances of the Company. No borrowings
will be incurred by the Company in respect of any repurchase of Ordinary Shares 
pursuant to the Repurchase Agreement.

**Conditionality**

There is no guarantee that any Ordinary Shares will be acquired pursuant to the 
Tender Offer. The Tender Offer is conditional on the passing of the Resolution at
the General Meeting and the other Tender Conditions specified in Part V of the Circular.
As mentioned above, non-binding Letters of Intent to vote in favour of the Resolution
have been received from certain Shareholders.

The Tender Offer is also conditional on receipt of valid tenders in respect of at
least  5,813,953 Ordinary Shares (representing approximately 2.5 per cent. of the
Company’s issued Ordinary Share capital as at the Latest Practicable Date) by the
Closing Date and there continuing to be valid tenders in respect of at least such
number of Ordinary Shares, and the Tender Offer not having been terminated in accordance
with its terms and the Company having confirmed to Zeus that it will not exercise
its right to require Zeus not to proceed with the Tender Offer.

The Board has reserved the right, at any time prior to the Tender Offer becoming
unconditional, to require Zeus not to proceed with the Tender Offer if the Board
concludes that the implementation of the Tender Offer is no longer in the best interests
of the Company and/or Shareholders as a whole. The Board has also reserved the right,
at any time prior to the announcement of the results of the Tender Offer, with the
prior consent of Zeus, to revise the aggregate value of the Tender Offer (subject,
however, to the aggregate value not exceeding £10 million), or to extend the period
during which the Tender Offer is open, based on market conditions and/or other factors,
subject to compliance with applicable legal and regulatory requirements.

**Action to be taken by Eligible Shareholders**

The Tender Form to be completed by Eligible Shareholders who hold their Ordinary
Shares in certificated form contains a box to enable those Shareholders to specify
the total number of Ordinary Shares that they wish to tender. If a Shareholder executes
and returns a Tender Form (by signing Box 2) but does not insert an ‘X’ or a number
in Box 1b of the Tender Form, that Shareholder will be deemed to have tendered their
Basic Entitlement.

Eligible Shareholders who hold their Ordinary Shares in uncertificated form and 
who wish to tender their Ordinary Shares should send a TTE Instruction through CREST
to the member account, further details of which are set out in Part VII of the Circular
specifying the total number of Ordinary Shares that they wish to tender.

All successfully tendered Ordinary Shares purchased by Zeus (acting as principal
and not as agent, nominee or trustee) will be repurchased from Zeus by the Company
under the terms of the Repurchase Agreement.

**Buyback Programme**

Pursuant to the Buyback Programme, as at the Latest Practicable Date, the Company
had bought back  8,357,417 Ordinary Shares from Shareholders for a total gross purchase
consideration of £3,444,318. Those purchases were made pursuant to the AGM Authority.
The Company has paused the Buyback Programme until after completion of the Tender
Offer, with approximately £6.6 million remaining available to satisfy purchases 
of Ordinary Shares made in accordance with the AGM Authority.

Separate shareholder authority to make market purchases in connection with the Tender
Offer is being sought by way of the Resolution which will be proposed at the General
Meeting. 

Shareholders should note that the authority being sought for the Tender Offer pursuant
to the Resolution is in addition to, and not in substitution for, the authority 
provided pursuant to the AGM Authority. However the authority being sought for the
Tender Offer pursuant to the Resolution will be specific to that purpose. Accordingly,
if there is insufficient take-up under the Tender Offer after taking into account
tenders pursuant to the Basic Entitlement and any Excess Entitlements, the total
capital returned to Shareholders under the Buyback Programme and the Tender Offer
combined will be less than £20 million in aggregate.

**Taxation**

Shareholders should be aware that there will be tax considerations that they should
take into account when deciding whether or not to participate in the Tender Offer.
Summary details of certain UK taxation considerations are set out in Part VIII of
the Circular.

Shareholders are strongly advised to obtain independent tax advice regarding their
own tax position. Shareholders who are in any doubt as to their tax position or 
who are subject to tax in a jurisdiction other than the United Kingdom should consult
an appropriate professional adviser.

**Advantages and Disadvantages of the Tender Offer**

Advantages of the Tender Offer

The Directors believe that making the Tender Offer on the terms set out in the Circular
is in the interests of Shareholders as a whole because:

·    the Tender Offer provides an opportunity for those Shareholders who wish to
realise some or all of their investment in the Company to receive cash;

·     the Tender Offer is being conducted at a premium to the prevailing share price
as at the Latest Practicable Date;

·     the Tender Offer is available to all Eligible Shareholders regardless of the
size of their holdings;

·   the Tender Offer permits Shareholders who wish to retain their current investment
in the Company and their Ordinary Shares to do so, as no Shareholder is required
to participate in the Tender Offer; and

·   the Tender Offer enables Ordinary Shares to be sold free of commissions or dealing
charges that would otherwise be payable if Shareholders were to sell their Ordinary
Shares through their broker.

Disadvantages of the Tender Offer

In considering the Tender Offer, the Directors believe Shareholders should have 
regard to the following disadvantages that they may experience if they opt to accept
the Tender Offer or if they opt to retain their Ordinary Shares and not accept the
Tender Offer (as applicable):

·    in order to pay the consideration to which Shareholders are entitled pursuant
to valid tenders of Ordinary Shares accepted by Zeus (and which the Company will
then be obliged to repurchase from Zeus), the Company will use a significant amount
of its available cash which will then be unavailable for deployment in the Company’s
operations or for other purposes;

·     the market price of the Ordinary Shares may change during the course of the
period that the Tender Offer is open. Therefore, there can be no certainty as to
whether the Tender Price will be greater or less than the price at which the Ordinary
Shares could be sold in the market at any time;

·    Shareholders tendering Ordinary Shares under the Tender Offer will receive 
the Tender Price, which may be less than the price at which they bought their Ordinary
Shares; and

·    Tender Forms and TTE Instructions, once submitted, are irrevocable. The price
of the Ordinary Shares may rise or fall following submission of a Tender Form or
TTE Instruction. After settlement of a TTE Instruction, the Shareholder will not
be able to access the Ordinary Shares concerned in CREST for any transaction or 
charging purposes.

**Overseas Shareholders**

The attention of Shareholders who are resident in, or a citizen of, a jurisdiction
outside of the United Kingdom and the Isle of Man (Overseas Shareholders) is drawn
to section 10 Part V of the Circular.

**General Meeting**

Implementation of the Tender Offer requires the approval of the Resolution by Shareholders
at a general meeting of the Company.

Accordingly, a Notice of General Meeting is set out at the end of the Circular convening
the General Meeting to be held at the offices of the Company at Forrest House, Ronaldsway,
Isle of Man, IM9 2RG at 9.00 a.m. on 30 April 2026.

The Resolution will be proposed at the General Meeting as a special resolution, 
the passing of which requires not less than 75 per cent. of the votes cast (whether
in person or by proxy) to be in favour.

The Resolution seeks authority to make market purchases of Ordinary Shares in connection
with the Tender Offer. The Resolution specifies the maximum number of Ordinary Shares
which may be acquired, and the fixed price at which Ordinary Shares may be acquired,
pursuant to this authority. The authority sought will expire on 31 July 2026 at 
the conclusion of the Company’s next annual general meeting to be held.

**Actions to be taken at the General Meeting**

Set out at the end of the Circular you will find a notice convening a General Meeting
to be held at the offices of the Company at Forrest House, Ronaldsway, Isle of Man,
IM9 2RG at 9.00 a.m. on 30 April 2026 to consider and, if thought fit, approve the
Resolution.

Shareholders may appoint a proxy online via the Investor Centre app or by accessing
the web browser at https://uk.investorcentre.mpms.mufg.com/. In order to appoint
a proxy using the Website, Shareholders will need to log into their Investor Centre
account, or register if they have not previously done so. To register, Shareholders
will need to identify themselves with their Investor Code which is detailed on their
share certificate or available from the Company’s Registrars, MUFG Corporate Markets,
on Tel: 0371 664 0321 or by emailing shareholderenquiries@cm.mpms.mufg.com. Shareholders
who prefer to use a hard copy Form of Proxy may request one from MUFG Corporate 
Markets using the contact details above. Calls are charged at the standard geographic
rate and will vary by provider. Calls outside the United Kingdom will be charged
at the applicable international rate. Lines are open between 9.00 a.m. – 5.30 p.
m., Monday to Friday excluding public holidays in England and Wales. MUFG Corporate
Markets cannot provide advice on the merits of the Tender Offer or the Resolution
and cannot give any financial, legal or tax advice.

Whether or not Shareholders intend to be present at the General Meeting, they are
requested to appoint a proxy and submit their proxy appointment in accordance with
the instructions set out in the Notice of General Meeting as soon as possible and,
in any event, so as to be received by the Company’s registrars, MUFG Corporate Markets,
not later than 48 hours (excluding non-working days) before the General Meeting 
is scheduled to begin, meaning it should be returned by 9.00a.m. on 28 April 2026.
The completion and return of a proxy appointment will not preclude the Shareholders
from attending the General Meeting and voting in person should they so wish.

**If you wish to participate in the Tender Offer**

If you are an Eligible Shareholder and hold your Ordinary Shares in certificated
form and you wish to tender some or all of your Ordinary Shares, you should complete
the Tender Form in accordance with the instructions printed on it and in Part V 
of the Circular and return it by post in the accompanying reply-paid envelope (for
use in the UK only) to MUFG Corporate Markets, together with your share certificate(
s) in respect of the Ordinary Shares tendered.

If you are an Eligible Shareholder and hold your Ordinary Shares in uncertificated
form and you wish to tender some or all of your Ordinary Shares, you should send
a TTE Instruction and follow the procedures set out in Part VII of the Circular 
in respect of tendering uncertificated Ordinary Shares.

Shareholders who do not wish to participate in the Tender Offer should not complete
the Tender Form and should not make or arrange for a TTE Instruction.

If you have any questions about the procedure for tendering Ordinary Shares or making
a TTE Instruction, you require extra copies of the Circular or the Tender Form or
you want help filling in the Tender Form, please telephone the Shareholder Helpline
on 0371 664 0321. Lines are open from 9.00 a.m. to 5.30 p.m. (London time) Monday
to Friday (except public holidays in England and Wales). Please note that calls 
to these numbers may be monitored or recorded for security and training purposes.

Please note that for legal reasons the Shareholder Helpline will only be able to
provide information contained in the Circular and the accompanying Tender Form and
will be unable to give advice on the merits of the Tender Offer or to provide financial,
investment or taxation advice.

You are advised to read all the information contained in the Circular before deciding
on the course of action you will take in respect of the General Meeting and the 
Tender Offer.

The results of the General Meeting will be announced through a Regulatory Information
Service and the Company’s website as soon as possible once known. It is expected
that this will be on 30 April 2026.

**Board intentions to tender Ordinary Shares**

The Directors have indicated that they do not intend to tender their Ordinary Shares(
or any part thereof) under the Tender Offer.

**Recommendation**

The Directors unanimously recommend that Shareholders vote in favour of the Resolution
as the Directors intend to do in respect of their own beneficial holdings of Ordinary
Shares, amounting in aggregate to 3,291,314 Ordinary Shares (representing approximately
1.4 per cent. of the issued share capital of the Company as at the Latest Practicable
Date).

Shareholders should note that if they vote in favour of the Resolution at the General
Meeting, they are not obliged to participate in the Tender Offer. The Directors 
are not making any recommendation to Eligible Shareholders as to whether or not 
they should tender their Ordinary Shares in the Tender Offer. Shareholders should
consider whether the Ordinary Shares remain a suitable investment in light of their
own personal circumstances and investment objectives as well as the financial performance
and future prospects of the Group, noting the non-exhaustive list of risks that 
the Company is subject to, and the advantages and disadvantages of tendering Ordinary
Shares under the Tender Offer outlined above.

If Eligible Shareholders are in any doubt as to what action they should take, they
should seek their own independent professional advice.

Share on:
